Cytokinetics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.About CYTK
Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.
CYTK Key Statistics
Stock Snapshot
The current Cytokinetics(CYTK) stock price is $58.70, with a market capitalization of 7.14B. The stock trades at a price-to-earnings (P/E) ratio of -11.64.
On 2025-11-05, Cytokinetics(CYTK) stock traded between a low of $58.70 and a high of $60.77. Shares are currently priced at $58.70, which is 0.0% above the low and -3.4% below the high.
Cytokinetics(CYTK) shares are trading with a volume of 979.12K, against a daily average of 1.8M.
During the past year, Cytokinetics(CYTK) stock moved between $29.31 at its lowest and $64.13 at its peak.
During the past year, Cytokinetics(CYTK) stock moved between $29.31 at its lowest and $64.13 at its peak.
CYTK News
Investors in Cytokinetics (CYTK) are reacting after news surfaced of a class action lawsuit claiming the company misrepresented key aspects of its aficamten dru...
JPMorgan raised the firm’s price target on Cytokinetics (CYTK) to $70 from $55 and keeps an Overweight rating on the shares. The firm upped the price target aft...
In October 2025, Cytokinetics disclosed that the FDA extended its review period for the cardiac drug aficamten due to the omission of a required Risk Evaluation...